IL89746A0 - 4-aryl(or heteroaryl)-4-piperidine(or pyrrolidine or hexahydroazepine)carbinols and pharmaceutical compositions containing them - Google Patents
4-aryl(or heteroaryl)-4-piperidine(or pyrrolidine or hexahydroazepine)carbinols and pharmaceutical compositions containing themInfo
- Publication number
- IL89746A0 IL89746A0 IL89746A IL8974689A IL89746A0 IL 89746 A0 IL89746 A0 IL 89746A0 IL 89746 A IL89746 A IL 89746A IL 8974689 A IL8974689 A IL 8974689A IL 89746 A0 IL89746 A0 IL 89746A0
- Authority
- IL
- Israel
- Prior art keywords
- carbinols
- aryl
- hexahydroazepine
- pyrrolidine
- piperidine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
- C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D223/04—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with only hydrogen atoms, halogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17435688A | 1988-03-28 | 1988-03-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL89746A0 true IL89746A0 (en) | 1989-09-28 |
Family
ID=22635870
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL89746A IL89746A0 (en) | 1988-03-28 | 1989-03-27 | 4-aryl(or heteroaryl)-4-piperidine(or pyrrolidine or hexahydroazepine)carbinols and pharmaceutical compositions containing them |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0337167B1 (da) |
| JP (1) | JP2907860B2 (da) |
| KR (1) | KR0140891B1 (da) |
| AT (1) | ATE109465T1 (da) |
| AU (1) | AU623637B2 (da) |
| CA (1) | CA1337418C (da) |
| DE (1) | DE68917185T2 (da) |
| DK (1) | DK145689A (da) |
| ES (1) | ES2056990T3 (da) |
| FI (1) | FI94240C (da) |
| HU (1) | HU213671B (da) |
| IE (1) | IE65811B1 (da) |
| IL (1) | IL89746A0 (da) |
| MY (1) | MY103990A (da) |
| NO (1) | NO891260L (da) |
| NZ (1) | NZ228479A (da) |
| PT (1) | PT90127B (da) |
| RU (1) | RU1836346C (da) |
| ZA (1) | ZA892171B (da) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU638852B2 (en) * | 1990-07-24 | 1993-07-08 | Merrell Dow Pharmaceuticals Inc. | Novel substituted piperidines and their use as inhibitors of cholesterol synthesis |
| DE4112353A1 (de) * | 1991-04-16 | 1992-10-22 | Basf Ag | 1,3,4-trisubstituierte piperidin-derivate, ihre herstellung und verwendung |
| DE4215213A1 (de) * | 1992-05-09 | 1993-11-11 | Merck Patent Gmbh | Arylacetamide |
| CA2146767A1 (en) * | 1992-10-28 | 1994-05-11 | Timothy Harrison | 4-arylmethyloxymethyl piperidines as tachykinin antagonists |
| AU2002230665A1 (en) * | 2000-12-06 | 2002-06-18 | Sepracor, Inc. | 4,4-disubstituted piperidines for use as dopamine, serotonin and norepinephrine ligands |
| CA2463518A1 (en) * | 2001-10-16 | 2003-04-24 | Endo Pharmaceuticals Inc. | Carbinols for the treatment of neuropathic dysfunction |
| US20070249607A1 (en) | 2006-04-17 | 2007-10-25 | Bristol-Myers Squibb Company | Nk-1 and serotonin transporter inhibitors |
| US8071778B2 (en) | 2006-07-27 | 2011-12-06 | Bristol-Myers Squibb Company | Substituted heterocyclic ethers and their use in CNS disorders |
| US8026257B2 (en) | 2007-07-11 | 2011-09-27 | Bristol-Myers Squibb Company | Substituted heterocyclic ethers and their use in CNS disorders |
| BR112019016827A2 (pt) | 2017-02-17 | 2020-04-07 | Trevena Inc | compostos moduladores de receptor delta-opioide contendo aza-heterocíclico com 5 membros, métodos de uso e produção dos mesmos |
| JP7185633B2 (ja) * | 2017-02-17 | 2022-12-07 | トレベナ・インコーポレイテッド | ７員アザ複素環を含有するデルタ－オピオイド受容体調節化合物、その使用方法及び製造方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB888657A (en) * | 1958-07-14 | 1962-01-31 | J F Macfarlan & Co Ltd | Piperidine carbinols |
| US3080372A (en) * | 1960-03-25 | 1963-03-05 | Res Lab Dr C Janssen | 1-aroylalkyl-4-arylpiperidine derivatives |
| BE775611A (fr) * | 1970-11-24 | 1972-03-16 | Synthelabo | Derives de la (diphenyl-3,3 propyl-1)-1 piperidine, leur preparation etles medicaments qui en contiennent |
| US4284635A (en) * | 1978-11-29 | 1981-08-18 | Eli Lilly And Company | Analgesic 1,2,4,5-tetra-alkyl-4-arylpiperidines |
| US4485109A (en) * | 1982-05-07 | 1984-11-27 | E. I. Du Pont De Nemours And Company | 4-Aryl-4-piperidinecarbinols |
| ZA833253B (en) * | 1982-05-07 | 1984-12-24 | Du Pont | 4-aryl-4-piperidinecarbinols |
-
1989
- 1989-02-22 CA CA000591753A patent/CA1337418C/en not_active Expired - Lifetime
- 1989-03-22 NO NO89891260A patent/NO891260L/no unknown
- 1989-03-22 DK DK145689A patent/DK145689A/da not_active Application Discontinuation
- 1989-03-22 ES ES89105083T patent/ES2056990T3/es not_active Expired - Lifetime
- 1989-03-22 ZA ZA892171A patent/ZA892171B/xx unknown
- 1989-03-22 DE DE68917185T patent/DE68917185T2/de not_active Expired - Lifetime
- 1989-03-22 AT AT89105083T patent/ATE109465T1/de not_active IP Right Cessation
- 1989-03-22 EP EP89105083A patent/EP0337167B1/en not_active Expired - Lifetime
- 1989-03-23 IE IE91389A patent/IE65811B1/en not_active IP Right Cessation
- 1989-03-23 NZ NZ228479A patent/NZ228479A/en unknown
- 1989-03-27 RU SU894613736A patent/RU1836346C/ru active
- 1989-03-27 MY MYPI89000381A patent/MY103990A/en unknown
- 1989-03-27 IL IL89746A patent/IL89746A0/xx not_active IP Right Cessation
- 1989-03-28 KR KR1019890003866A patent/KR0140891B1/ko not_active Expired - Fee Related
- 1989-03-28 PT PT90127A patent/PT90127B/pt not_active IP Right Cessation
- 1989-03-28 FI FI891473A patent/FI94240C/fi not_active IP Right Cessation
- 1989-03-28 HU HU891532A patent/HU213671B/hu not_active IP Right Cessation
- 1989-03-28 AU AU31717/89A patent/AU623637B2/en not_active Ceased
- 1989-03-28 JP JP1074129A patent/JP2907860B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| KR890014475A (ko) | 1989-10-23 |
| HUT50787A (en) | 1990-03-28 |
| PT90127B (pt) | 1994-06-30 |
| NZ228479A (en) | 1991-12-23 |
| FI891473L (fi) | 1989-09-29 |
| ZA892171B (en) | 1990-11-28 |
| PT90127A (pt) | 1989-11-10 |
| DE68917185D1 (de) | 1994-09-08 |
| CA1337418C (en) | 1995-10-24 |
| DK145689D0 (da) | 1989-03-22 |
| DE68917185T2 (de) | 1995-01-05 |
| DK145689A (da) | 1989-09-29 |
| FI94240C (fi) | 1995-08-10 |
| AU623637B2 (en) | 1992-05-21 |
| ES2056990T3 (es) | 1994-10-16 |
| RU1836346C (ru) | 1993-08-23 |
| HU213671B (en) | 1997-09-29 |
| AU3171789A (en) | 1989-09-28 |
| FI94240B (fi) | 1995-04-28 |
| JPH0249766A (ja) | 1990-02-20 |
| IE890913L (en) | 1989-09-28 |
| MY103990A (en) | 1993-10-30 |
| FI891473A0 (fi) | 1989-03-28 |
| JP2907860B2 (ja) | 1999-06-21 |
| KR0140891B1 (ko) | 1998-06-01 |
| EP0337167A1 (en) | 1989-10-18 |
| NO891260D0 (no) | 1989-03-22 |
| IE65811B1 (en) | 1995-11-15 |
| EP0337167B1 (en) | 1994-08-03 |
| NO891260L (no) | 1989-09-29 |
| ATE109465T1 (de) | 1994-08-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA915326B (en) | Piperidine,tetrahydropyridine and pyrrolidine derivatives,process for preparing these and pharmaceutical compositions containing them | |
| NO961686D0 (no) | Heteroarylpiperidiner, pyrrolidiner og piperaziner og deres anvendelse som antipsykotika og analgetika | |
| MY113036A (en) | Oral liquid formulation containing paroxetine | |
| HUT75113A (en) | 4-substituted piperidine derivatives useful as neurokinin antagonists | |
| IL86618A (en) | Piperidines and/or tetrahydropyridines,their preparation and pharmaceutical compositions comprising them | |
| BG102966A (en) | Carboxamide derivatives of pyrrolidines, piperidines and hexahydroazepines for the treatment of thrombotic diseases | |
| NZ227643A (en) | 1,4 disubstituted piperidinyl derivatives and pharmaceutical compositions | |
| GB9305718D0 (en) | Medicaments | |
| HUP9904622A3 (en) | 1,4-di-sustituted piperidines as muscarinic antagonists | |
| ZA892171B (en) | 4-aryl-4-piperidine(or pyrrolidine or hexahydroazepine)carbinols and heterocyclic analogs thereof | |
| IL91689A0 (en) | 1-((diarylmethoxy)alkyl)pyrrolidines and piperidines,their preparation and pharmaceutical compositions containing them | |
| ES8300743A1 (es) | Un procedimiento para la preparacion de nuevos derivados de 1-(4-arilciclohexil)-piperidinas. | |
| JPS6419066A (en) | Dihydropyridineamides | |
| AU4692889A (en) | New piperidin-2,6-diones used to prepare piperidines useful as medicaments | |
| IL109866A0 (en) | Crystalline 3-(4-hexyloxy-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyridine (+) l-hydrogentartrate, its preparation and pharmaceutical compositions containing it | |
| NZ225303A (en) | 2,5 dialkyl-3-phenyl piperidine derivatives and pharmaceutical compositions | |
| WO1992005152A3 (en) | Process for producing polyhydroxylated piperidines and pyrrolidines and compounds thereof | |
| DE69012619D1 (de) | Bis(1-Hydrocarbyloxy-2,2,6,6-tetramethylpiperidin-4-yl)-amin-derivate und stabilisierte Zusammensetzungen. | |
| GR3014927T3 (en) | Disubstituted piperidines and pyrrolidines as anticholinergic agents. | |
| EP0186055A3 (en) | Antimycotic gel preparations | |
| GR3002981T3 (en) | 1-((2-fluorophenyl)(4-fluorophenyl)phenylmethyl)-1h-imidazole | |
| AU2861589A (en) | 1,2,3,6/1,2,5,6-Tetrahydropyridine derivatives | |
| AU610456B2 (en) | 4-ethyl-3-(substituted phenyl)-1-(3-trifluoromethylphenyl) -2-pyrrolidinone derivatives, processes for the preparation and use thereof, herbicidal compositions containing them | |
| DE59700961D1 (de) | Verfahren zur Herstellung von 4-Amino-2,2,6,6-tetramethylpiperidin (TAD) über das Zwischenprodukt 2,2,6,6-Tetramethyl-4-[(2,2,6,6-tetramethyl-4-piperidyliden)amino]-piperidin | |
| SI0765311T1 (en) | 4-aryl-1-(indanmethyl, dihydrobenzofuranmethyl or dihydrobenzothiophenemethyl)piperidines, tetrahydropyridines or piperazines |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| KB | Patent renewed | ||
| RH | Patent void | ||
| KB | Patent renewed | ||
| MM9K | Patent not in force due to non-payment of renewal fees |